1 Min Read
May 18 (Reuters) - Cosmo Pharmaceuticals NV:
* FDA ACCEPTS NEW DRUG APPLICATION SUBMISSION FOR RIFAMYCIN SV MMX AND SETS PDUFA DATE FOR NOVEMBER 16, 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.